Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)
Condition(s):Osteoporosis, PostmenopausalLast Updated:January 28, 2009Completed
Hide Studies Not Open or Pending
Condition(s):Osteoporosis, PostmenopausalLast Updated:January 28, 2009Completed
Condition(s):OsteoporosisLast Updated:December 21, 2015Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:March 25, 2020Unknown status
Condition(s):OsteoporosisLast Updated:June 26, 2018Completed
Condition(s):Post Menopausal OsteoporosisLast Updated:May 2, 2016Completed
Condition(s):Hepatic Osteodystrophy; Liver CirrhosisLast Updated:September 1, 2023Not yet recruiting
Condition(s):Hematological MalignanciesLast Updated:September 13, 2018Completed
Condition(s):Primary OsteoporosisLast Updated:August 2, 2012Completed
Condition(s):Renal TransplantLast Updated:March 24, 2010Unknown status
Condition(s):Post Menopausal OsteoporosisLast Updated:March 29, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.